Abstract
Background:
Diffuse Large B-Cell Lymphoma is a classification of non-Hodgkins lymphoma cancers. DLBCL is extremely difficult to consistently treat because of its heterogeneity, meaning treatment must be precise and tailored. Some methods of determining prognoses and care include the IPI, COO, Single-biomarker...
Malaika Koreshi, E. Engh, Suhas Kundurthi et al.· INNOVAPATH· 0 citations
Backgrounds:
Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter, better known as the ESKAPE group are gram-negative bacteria that are multi-drug resistant. Due to this, ESKAPE bacterial infections have become increasingly difficult to tr...
E. Engh, Angelica Rodriguez, Malaika Koreshi et al.· INNOVAPATH· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.